Page last updated: 2024-10-28

hydroxychloroquine and Genetic Diseases, X-Chromosome Linked

hydroxychloroquine has been researched along with Genetic Diseases, X-Chromosome Linked in 3 studies

Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.

Research Excerpts

ExcerptRelevanceReference
"Pyridostigmine improved weakness in the centronuclear myopathy patient, but not in the distal myopathy patient."1.51Neuromuscular transmission defects in myopathies: Rare but worth searching for. ( Elahi, B; Laughlin, RS; Liewluck, T; Litchy, WJ; Milone, M, 2019)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Soresina, A1
Moratto, D1
Chiarini, M1
Paolillo, C1
Baresi, G1
FocĂ , E1
Bezzi, M1
Baronio, B1
Giacomelli, M1
Badolato, R1
Alkan, G1
Artac, H1
Oz, SKT1
Emiroglu, M1
Elahi, B1
Laughlin, RS1
Litchy, WJ1
Milone, M1
Liewluck, T1

Other Studies

3 other studies available for hydroxychloroquine and Genetic Diseases, X-Chromosome Linked

ArticleYear
Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover.
    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2020, Volume: 31, Issue:5

    Topics: Adult; Agammaglobulinemia; Anti-Bacterial Agents; Betacoronavirus; Coronavirus Infections; COVID-19;

2020
Management of COVID-19 pneumonia in a child with NEMO deficiency.
    Immunologic research, 2021, Volume: 69, Issue:4

    Topics: Amides; Antiviral Agents; Azithromycin; Child; COVID-19; COVID-19 Serotherapy; Ectodermal Dysplasia;

2021
Neuromuscular transmission defects in myopathies: Rare but worth searching for.
    Muscle & nerve, 2019, Volume: 59, Issue:4

    Topics: Cholinesterase Inhibitors; Cohort Studies; Electrodiagnosis; Electromyography; Female; Genetic Disea

2019